Columnist: CIRM Should Mull Effects of its Research Effort
Los Angeles Times columnist Michael Hiltzik writes that the search process for a new board chair for the California Institute for Regenerative Medicine "has been a missed opportunity" for the board to consider broader issues, such as whether CIRM's existence has diminished state funding for other research efforts. Hiltzik adds, "There's no question that stem cell research is important and potentially groundbreaking. But with every budget year, the folly of generously funding research in one research field while everything else withers away grows more obvious."
- "Missed Opportunities at California Stem Cell Research Agency" (Hiltzik, Los Angeles Times, 6/7).